Majid Zeidi

516 total citations
21 papers, 368 citations indexed

About

Majid Zeidi is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Majid Zeidi has authored 21 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Dermatology and 7 papers in Rheumatology. Recurrent topics in Majid Zeidi's work include Dermatology and Skin Diseases (6 papers), Immune Cell Function and Interaction (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Majid Zeidi is often cited by papers focused on Dermatology and Skin Diseases (6 papers), Immune Cell Function and Interaction (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Majid Zeidi collaborates with scholars based in United States, Iran and South Korea. Majid Zeidi's co-authors include Victoria P. Werth, Hee Joo Kim, Muhammad M. Bashir, Rui Feng, S.M. Peña, Diletta Bonciani, Josef Symon S. Concha, Maria Wysocka, Christina E. Bax and Elizabeth Robinson and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Majid Zeidi

21 papers receiving 367 citations

Peers

Majid Zeidi
S. Matthew Fitzgerald United States
A.J. Frew United Kingdom
Sahil Sekhon United States
M. Richter Canada
S. Matthew Fitzgerald United States
Majid Zeidi
Citations per year, relative to Majid Zeidi Majid Zeidi (= 1×) peers S. Matthew Fitzgerald

Countries citing papers authored by Majid Zeidi

Since Specialization
Citations

This map shows the geographic impact of Majid Zeidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majid Zeidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majid Zeidi more than expected).

Fields of papers citing papers by Majid Zeidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Majid Zeidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majid Zeidi. The network helps show where Majid Zeidi may publish in the future.

Co-authorship network of co-authors of Majid Zeidi

This figure shows the co-authorship network connecting the top 25 collaborators of Majid Zeidi. A scholar is included among the top collaborators of Majid Zeidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Majid Zeidi. Majid Zeidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werth, Victoria P., S.M. Peña, Majid Zeidi, et al.. (2022). Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial. Journal of Investigative Dermatology. 142(10). 2651–2659.e1. 37 indexed citations
2.
Maddukuri, Spandana, Jay Patel, Maria Wysocka, et al.. (2022). Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM. Arthritis Research & Therapy. 24(1). 12–12. 18 indexed citations
3.
Zeidi, Majid, Jay Patel, Krisha Desai, et al.. (2022). Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials. Lupus. 31(4). 472–481. 5 indexed citations
4.
Patel, Jay, Majid Zeidi, Maria Wysocka, et al.. (2021). Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness. Journal of Investigative Dermatology. 141(8). 1906–1914.e2. 20 indexed citations
6.
Bax, Christina E., et al.. (2020). The effects of immunostimulatory herbal supplements on autoimmune skin diseases. Journal of the American Academy of Dermatology. 84(4). 1051–1058. 25 indexed citations
7.
Zeidi, Majid, et al.. (2019). 1004 Increased tissue-resident memory T (TRM) cells and STAT3 expression in cutaneous lupus erythematosus patients refractory to antimalarials. Journal of Investigative Dermatology. 139(5). S174–S174. 4 indexed citations
8.
Zeidi, Majid, et al.. (2019). Recent Advances in Pharmacological Treatments of Adult Dermatomyositis. Current Rheumatology Reports. 21(10). 53–53. 6 indexed citations
9.
Li, Yingying, Majid Zeidi, Muhammad M. Bashir, Victoria P. Werth, & Min Liu. (2019). 054 Extracellular MAVS associates with microvesicles that can actively trigger IFNβ production. Journal of Investigative Dermatology. 139(5). S9–S9. 2 indexed citations
11.
Zeidi, Majid, Hee Joo Kim, & Victoria P. Werth. (2018). Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus. Journal of Investigative Dermatology. 139(2). 324–332. 35 indexed citations
12.
Zeidi, Majid, et al.. (2018). 442 Acute onset/exacerbation of dermatomyositis and Sjogrens Syndrome following ingestion of IsaLean® herbal supplement: Clinical and immunostimulatory findings. Journal of Investigative Dermatology. 138(5). S75–S75. 1 indexed citations
13.
Kim, Hee Joo, et al.. (2018). Itch in dermatomyositis: the role of increased skin interleukin-31. British Journal of Dermatology. 179(3). 669–678. 64 indexed citations
14.
Bashir, Muhammad M., et al.. (2017). Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus. Journal of Investigative Dermatology Symposium Proceedings. 18(2). S57–S63. 26 indexed citations
15.
Robinson, Elizabeth, et al.. (2017). Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro. Journal of Investigative Dermatology. 137(11). 2445–2447. 36 indexed citations
16.
17.
Zeidi, Majid & Jeffrey P. North. (2015). Sebaceous induction in dermatofibroma: a common feature of dermatofibromas on the shoulder. Journal of Cutaneous Pathology. 42(6). 400–405. 6 indexed citations
18.
Soltani, Ahmad, Zahra Pourpak, Zahra Alizadeh, et al.. (2014). Polymorphisms and serum level of mannose-binding lectin: an Iranian survey.. PubMed. 13(6). 428–32. 7 indexed citations
19.
Vaezjalali, Maryam, et al.. (2013). Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors. Hepatitis Monthly. 13(3). e6590–e6590. 32 indexed citations
20.
Ardalan, Farid Azmoudeh, et al.. (2010). Determination of lymphocyte subsets reference values in healthy Iranian men by a single platform flow cytometric method. Cytometry Part A. 77A(9). 890–894. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026